Nature's Sunshine Products Reports First Quarter 2016 Financial Results

  • Seventh consecutive quarter of net sales growth for NSP United States and NSP Canada
  • Net sales revenue of $82.4 million was down 1.8% year-over-year; up 1.3% year-over-year on a local currency basis
  • Earnings from continuing operations of $0.11 per diluted common share
  • Board of Directors approved a $0.10 per share quarterly cash dividend

LEHI, Utah, May 10, 2016 (GLOBE NEWSWIRE) -- Nature’s Sunshine Products, Inc. (NASDAQ:NATR), a leading natural health and wellness company engaged in the manufacture and direct selling of nutritional and personal care products, today reported its financial results for the first quarter ended March 31, 2016.

First Quarter 2016 Financial Highlights

  • Net sales revenue of $82.4 million decreased 1.8% compared to $83.9 million in the first quarter of 2015. On a local currency basis, net sales revenue increased 1.3% compared to the first quarter of 2015. Net sales revenue was negatively impacted by $2.5 million of unfavorable foreign currency exchange rate fluctuations as well as a $1.1 million decline in net sales in the NSP Russia, Central and Eastern Europe segment.
  • Net income from continuing operations was $1.8 million, or $0.11 per diluted common share, compared to $4.2 million, or $0.23 per diluted common share, in the first quarter of 2015. Earnings per diluted common share for the first quarter of 2016 were impacted by several factors including: the Company’s investment in China of approximately $0.07 per share and unfavorable changes in the effective tax rate of $0.02 per share.
  • Adjusted EBITDA was $4.2 million compared to $7.7 million in the first quarter of 2015. Adjusted EBITDA, which is a non-GAAP financial measure, is defined here as net income from continuing operations before taxes, depreciation, amortization and other income adjusted to exclude share-based compensation expense.

Management Commentary

“While the overall results for the quarter were depressed by continuing currency headwinds and challenges in Russia, Central and Eastern Europe, I am pleased with our first quarter results, which reflect the progress we have made toward returning Nature’s Sunshine to sustainable, long-term growth,” commented Gregory L. Probert, Chairman and Chief Executive Officer. “We were particularly pleased by the ongoing strong execution in NSP United States and NSP Canada, which both posted their seventh consecutive quarters of year-over-year local currency sales growth. In addition, Synergy WorldWide reported its best first quarter ever, which was driven by a successful business model and process improvements taking hold in Korea, Japan, Indonesia and Thailand. We also continue to make good progress in China and remain on-track to obtain our direct selling license in the third quarter of 2016.”

Mr. Probert continued, “The vast majority of the strength demonstrated in NSP United States and NSP Canada during the quarter was led by our patent-pending IN.FORM program. The new and improved IN.FORM program was clinically studied in the Hughes Center for Research and Innovation and formulated to improve gut health and support healthy metabolic function. IN.FORM has been integral to attracting new Distributors, and increasing engagement among existing Distributors in the United States and Canada. We believe IN.FORM will also be key to igniting growth in our Latin American markets. Furthermore, we made significant progress in streamlining our focus for Synergy WorldWide to a more unified sales and product strategy, the Elite Health System. This system has proven successful in Asia and we intend to expand it into other markets, such as other parts of Asia and Europe, later this year.” 

First Quarter 2016 Regional Sales by Operating Segment

    Net Sales Revenue by Operating Segment  
    Three Months

March 31,
  Three Months

March 31,
  Impact of
Impact of
NSP Americas:                      
NSP North America   $ 38,306   $ 38,174   0.3 % $ (301 ) 1.1 %
NSP Latin America   6,877   8,336   (17.5 ) (596 ) (10.4 )
    45,183   46,510   (2.9 ) (897 ) (0.9 )
NSP Russia, Central and Eastern Europe   6,352   7,443   (14.7 ) (53 ) (13.9 )
Synergy WorldWide:                      
Synergy Asia Pacific   20,816   18,698   11.3   (1,434 ) 19.0  
Synergy Europe   6,257   6,728   (7.0 ) (143 ) (4.9 )
Synergy North America   2,775   3,342   (17.0 )   (17.0 )
    29,848   28,768   3.8   (1,577 ) 9.2  
China and New Markets   1,019   1,157   (11.9 )   (11.9 )
    $ 82,402   $ 83,878   (1.8 )% $ (2,527 ) 1.3 %

Active Distributors and Customers by Segment (1)

    As of March 31, 2016   As of December 31, 2015  
& Customers
  Managers   Distributors
& Customers
NSP Americas   133,800   7,300   131,600   6,500  
NSP Russia, Central and Eastern Europe   65,200   2,800   72,000   2,800  
Synergy WorldWide   54,400   3,700   60,800   3,400  
China and New Markets          
    253,400   13,800   264,400   12,700  

(1)   Active Distributors and customers include Nature’s Sunshine Products’ independent Distributors and customers who have purchased products directly from the Company for resale and/or personal consumption during the previous three months ended as of the date indicated.  Total Manager, Distributors and Customers, which includes those who have made a purchase in the last twelve months, was 573,200 as of March 31, 2016.

Cash Flow and Balance Sheet Highlights

  • Net cash provided by operating activities was $2.9 million compared to $0.9 million of cash used in operating activities for the three months ended March 31, 2015.
  • Cash and cash equivalents at March 31, 2016 were $46.4 million, compared to $41.4 million at December 31, 2015.
  • The Company’s Board of Directors approved a quarterly cash dividend of $0.10 per share, payable on June 6, 2016, to shareholders of record as of the close of business on May 25, 2016. Dividend payments were $1.9 million during the first quarter of 2016. 

Conference Call

Nature’s Sunshine Products will host a conference call to discuss its first quarter 2016 results on May 10, 2016 at 4:30 PM Eastern Time.  The toll-free dial-in number for callers in the U.S. and Canada is 1-877-407-0789, conference ID: 13634141.  International callers can dial 1-201-689-8562, conference ID: 13634141.  A replay will be available from May 10, 2016 at 7:30 PM Eastern Time through May 24, 2016 at 11:59 PM Eastern Time by dialing 1-877-870-5176 (U.S. and Canada) or 1-858-384-5517 (International), replay PIN: 13634141.  The call will also be webcast live and will be available on the Investors section of Nature’s Sunshine Products’ website at for 90 days.

About Nature’s Sunshine Products

Nature’s Sunshine Products (NASDAQ:NATR), a leading natural health and wellness company, markets and distributes nutritional and personal care products through a global direct sales force of over 573,000 independent Managers, Distributors and customers in more than 40 countries.  Nature’s Sunshine manufactures most of its products through its own state-of-the-art facilities to ensure its products continue to set the standard for the highest quality, safety and efficacy on the market today. The Company has four reportable business segments that are divided based on the characteristics of their Distributor base, similarities in compensation plans, as well as the internal organization of NSP’s officers and their responsibilities (NSP Americas; NSP Russia, Central and Eastern Europe; Synergy WorldWide; and China and New Markets). The Company also supports health and wellness for children around the world through its partnership with the Sunshine Heroes Foundation.  Additional information about the Company can be obtained at its website,

Cautionary Statement Regarding Forward-Looking Statements

This press release contains forward-looking statements regarding the Company’s future business expectations, which are subject to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may include, but are not limited to, statements relating to the Company’s objectives, plans and strategies. All statements (other than statements of historical fact) that address activities, events or developments that the Company intends, expects, projects, believes or anticipates will or may occur in the future are forward-looking statements. These statements are often characterized by terminology such as “believe,” “hope,” “may,” “anticipate,” “should,” “intend,” “plan,” “will,” “expect,” “estimate,” “project,” “positioned,” “strategy” and similar expressions, and are based on assumptions and assessments made by management in light of their experience and their perception of historical trends, current conditions, expected future developments and other factors they believe to be appropriate. Forward-looking statements are not guarantees of future performance and are subject to risks and uncertainties, including the following.

  • any negative consequences resulting from the economy, including the availability of liquidity to the Company, its independent distributors and its suppliers or the willingness of its customers to purchase products;
  • its relationship with, and its inability to influence the actions of, its independent distributors, and other third parties with whom it does business;
  • improper activity by its employees or independent distributors;
  • negative publicity related to its products, ingredients, or direct selling organization and the nutritional supplement industry;
  • changing consumer preferences and demands;
  • its reliance upon, or the loss or departure of any member of, its senior management team, which could negatively impact its distributor relations and operating results;
  • increased state and federal regulatory scrutiny of the nutritional supplement industry, including, but not limited to targeting of ingredients, testing methodology and product claims;
  • the competitive nature of its business and the nutritional supplement industry;
  • regulatory matters governing its products, ingredients, the nutritional supplement industry, its direct selling program, or the direct selling market in which it operates;
  • legal challenges to its direct selling program or to the classification of its independent distributors;
  • risks associated with operating internationally and the effect of economic factors, including foreign exchange, inflation, disruptions or conflicts with the its third party importers, governmental sanctions, ongoing Ukraine and Russia political conflict, pricing and currency devaluation risks, especially in countries such as Ukraine, Russia and Belarus;
  • uncertainties relating to the application of transfer pricing, duties, value-added taxes, and other tax regulations, and changes thereto;
  • its dependence on increased penetration of existing markets;
  • cyber security threats and exposure to data loss;
  • its reliance on its information technology infrastructure;
  • the sufficiency of trademarks and other intellectual property rights;
  • changes in tax laws, treaties or regulations, or their interpretation;
  • taxation relating to its independent distributors;
  • product liability claims;
  • the full implementation of its joint venture for operations in China with Fosun Industrial Co., Ltd., as well as the legal complexities, unique regulatory environment and challenges of doing business in China generally;
  • its inability to register products for sale in Mainland China and difficulty or increased cost of importing products into Mainland China;
  • managing rapid growth in China; and
  • the slowing of the Chinese economy and/or the devaluation of the Chinese Renminbi.

These and other risks and uncertainties that could cause actual results to differ from predicted results are more fully detailed under the caption “Risk Factors” in  our Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 14, 2016.

All forward-looking statements speak only as of the date of this press release and are expressly qualified in their entirety by the cautionary statements included in or incorporated by reference into this press release. Except as is required by law, the Company expressly disclaims any obligation to publicly release any revisions to forward-looking statements to reflect events after the date of this press release. 

Non-GAAP Financial Measures

The Company has included information which has not been prepared in accordance with generally accepted accounting principles (GAAP), such as information concerning Adjusted EBITDA because management utilizes this information in the evaluation of its operations and believes that this measure is a useful indicator of the Company’s ability to fund its business. This non-GAAP financial measure should not be considered as an alternative to, or more meaningful than, U.S. GAAP net income as an indicator of the Company’s operating performance.  Moreover, Adjusted EBITDA, as presented by the Company, may not be comparable to similarly titled measures reported by other companies. Other companies may use the same or similarly named measures, but exclude different items, which may not provide investors with a comparable view of Nature’s Sunshine Products’ performance in relation to other companies. The Company has included a reconciliation of Adjusted EBITDA to net income, the most comparable GAAP measure, in the attached financial tables.            

(Amounts in thousands, except per share information)  
    Three Months Ended
March 31,
    2016   2015  
Net sales revenue   $ 82,402   $ 83,878  
Cost of sales   (22,020 ) (21,881 )
Gross profit   60,382   61,997  
Operating expenses:          
Volume incentives   29,877   30,337  
Selling, general and administrative   28,385   26,330  
Operating income   2,120   5,330  
Other income (loss), net   1,559   (318 )
Income before provision for income taxes   3,679   5,012  
Provision for income taxes   1,890   809  
Net income from continuing operations   1,789   4,203  
Income from discontinued operations     1,312  
Net income   1,789   5,515  
Net loss attributable to non-controlling interests   (280 ) (152 )
Net income attributable to common shareholders   $ 2,069   $ 5,667  
Earnings per common share:          
Basic earnings per share attributable to common shareholders:          
Net income from continuing operations   $ 0.11   $ 0.23  
Income from discontinued operations   $   $ 0.07  
Net income attributable to common shareholders   $ 0.11   $ 0.30  
Diluted earnings per share attributable to common shareholders:          
Net income from continuing operations   $ 0.11   $ 0.23  
Income from discontinued operations   $   $ 0.07  
Net income attributable to common shareholders   $ 0.11   $ 0.30  
Weighted average basic common shares outstanding   18,694   18,621  
Weighted average diluted common shares outstanding   19,130   19,192  
Dividends declared per common share   $ 0.10   $ 0.10  

(Amounts in thousands)  
    March 31,
  December 31,
Current assets:            
Cash and cash equivalents   $ 46,433   $ 41,420    
Accounts receivable, net of allowance for doubtful accounts of $181 and $190, respectively   8,146   7,700    
Investments available for sale   1,791   1,772    
Inventories   41,570   38,495    
Deferred income tax assets   4,795   5,021    
Prepaid expenses and other   7,262
Total current assets   109,997   101,518    
Property, plant and equipment, net   69,374   68,728    
Investment securities - trading   1,199   1,044    
Intangible assets, net   536   559    
Deferred income tax assets   17,105   17,339    
Other assets   12,264   11,332    
    $ 210,475   $ 200,520    
Liabilities and Shareholders’ Equity            
Current liabilities:            
Accounts payable   $ 8,658   $ 6,341    
Accrued volume incentives   17,313   14,913    
Accrued liabilities   21,226   23,726    
Deferred revenue   6,491   4,160    
Revolving credit facility payable   7,531   2,696    
Income taxes payable   1,019   1,300    
Total current liabilities   62,238   53,136    
Liability related to unrecognized tax benefits   7,777   7,809    
Deferred compensation payable   1,199   1,044    
Other liabilities   2.370   2,266    
Total liabilities   73,584   64,255    
Shareholders’ equity:            
Common stock, no par value, 50,000 shares authorized, 18,719 and 18,588 shares issued and outstanding, respectively   127,442   126,670    
Retained earnings   18,285   18,088    
Noncontrolling interests   2,470   2,750    
Accumulated other comprehensive loss   (11,306 ) (11,243 )  
Total shareholders’ equity   136,891   136,265    
    $ 210,475   $ 200,520    

(Amounts in thousands)  
    Three Months Ended
March 31,
    2016   2015  
Net income   $ 1,789   $ 5,515  
Adjustments to reconcile net income to net cash provided by operating activities:          
Provision for doubtful accounts   62   30  
Depreciation and amortization   1,170   996  
Share-based compensation expense   882   1,339  
Tax benefit from stock option exercise     (52 )
(Gain) loss on sale of property and equipment   68   (1,312 )
Deferred income taxes   589   50  
Purchase of trading investment securities   (177 ) (112 )
Proceeds from sale of trading investment securities   29   55  
Realized and unrealized losses (gains) on investments   (25 ) (46 )
Foreign exchange (gains) losses   (913 ) 351  
Changes in assets and liabilities:          
Accounts receivable   (432 ) (1,411 )
Inventories   (2,695 ) (1,989 )
Prepaid expenses and other current assets   (107
) (1,837 )
Other assets   (792 ) 74  
Accounts payable   2,607   3,010  
Accrued volume incentives   2,152   1,539  
Accrued liabilities   (3,433 ) (6,707 )
Deferred revenue   2,331   (461 )
Income taxes payable   (364 ) (268 )
Liability related to unrecognized tax benefits   (34 ) 230  
Deferred compensation payable   155   80  
Net cash provided by (used in) operating activities   2,862   (926 )
Purchases of property, plant and equipment   (1,312 ) (6,019 )
Proceeds from sale of property, plant and equipment   14   1,312  
Purchase of investments available for sale     (15 )
Net cash used in investing activities   (1,298 ) (4,722 )
Payments of cash dividends   (1,872 ) (1,865 )
Net borrowings on revolving credit facility   4,835   348  
Net proceeds from the exercise of stock options and issuance of stock units   59   1,640  
Payment of withholding taxes related to the vesting of restricted stock units   (169 )  
Tax benefit from stock option exercise     52  
Repurchase of common stock     (2,857 )
Net cash provided by (used in) financing activities   2,853   (2,682 )
Effect of exchange rates on cash and cash equivalents   596   (304 )
Net increase (decrease) in cash and cash equivalents   5,013   (8,634 )
Cash and cash equivalents at the beginning of the period   41,420   58,699  
Cash and cash equivalents at the end of the period   $ 46,433   $ 50,065  
Cash paid for income taxes   $ 1,474   $ 2,608
Cash paid for interest   20   25

(Amounts in thousands)  
    Three Months Ended
March 31,
      2016     2015  
Net income from continuing operations   $   1,789     $ 4,203  
Depreciation and amortization     1,170     996  
Share-based compensation expense     882     1,339  
Other (income) loss, net*     (1,559 )   318  
Provision (benefit) for income taxes     1,890     809  
Adjusted EBITDA   $ 4,172     $ 7,665  

* Other income (loss), net is primarily comprised of foreign exchange gains (losses), interest income, and interest expense.


Stephen M. Bunker                                        
Chief Financial Officer                                  
Nature’s Sunshine Products, Inc.                  
Lehi, Utah 84043                               
(801) 341-7303

Primary Logo

Source: Nature's Sunshine Products, Inc.